VACCELERATE - European Corona Vaccine Trial Accelerator Platform | VACCELERATE | Project | Results | H2020 | CORDIS

Resultado final

Validation of one or more innovative assays for monitoring the humoral immune response
D5.1 Living data document of all registered COVID-19 vaccine trials

Living data document of all registered COVID19 vaccine trials

VACCELERATE Internal Communication plan finalised
D4.4 Protocols for rapid deployment of collection and transport of specimens in line with the study objectives

Protocols for rapid deployment of collection and transport of specimens in line with the study objectives

Integrate laboratory capability questionnaire into EUVAP
Updated list of standardised data for vaccine trial protocol design
SOP system for vaccine clinical trials
Phase 2 vaccine trial master protocol templates, one for adults and one for children

Phase 2 vaccine trial master protocol templates one for adults and one for children

Report on use of interoperable data points and common collection protocols/systems

Report on use of interoperable data points and common collection protocolssystems

D7.1 Feasibility assessment of using data standards for vaccine trials (in collaboration with sponsors)

Feasibility assessment of using data standards for vaccine trials in collaboration with sponsors

"Plan for ""Exploitation and Dissemination of Results"" (PEDR)"

Plan for Exploitation and Dissemination of Results PEDR

Terms of Reference document for CTAP finalised, including CTAP members

Terms of Reference document for CTAP finalised including CTAP members

Lab support strategy to harmonise lab assays in the network
Standardised protocols for a set of core assays (ELISA and micro-neutralisation assays) for monitoring the humoral immune response and allow comparison across trials and trial sites

Standardised protocols for a set of core assays ELISA and microneutralisation assays for monitoring the humoral immune response and allow comparison across trials and trial sites

D10.4 Registration Number for study from WHO- or ICMJE-approved registry

Registration Number for study from WHO or ICMJEapproved registry

D9.7 Statistical Analysis Plan

Statistical Analysis Plan

D2.4 VACCELERATE Publication Policy

VACCELERATE Publication Policy

Cochrane Qualitative Evidence Synthesis on factors impacting recruitment to pandemic/epidemic vaccine trials

Cochrane Qualitative Evidence Synthesis on factors impacting recruitment to pandemicepidemic vaccine trials

Report on QMS for vaccine trials
D5.5 Updated report on unanswered COVID-19 vaccines and vaccination priority questions for future trials

Updated report on unanswered COVID19 vaccines and vaccination priority questions for future trials

D7.4 VACCELERATE data management and data sharing plan (DMP)

VACCELERATE data management and data sharing plan DMP

D1.4 Documents and templates for administrative and operational cross-consortium tasks finalised (presentations, letterheads, etc.)

Documents and templates for administrative and operational crossconsortium tasks finalised presentations letterheads etc

D1.3 Templates for annual thematic and financial reporting finalised

Templates for annual thematic and financial reporting finalised

Patient advocacy group needs for volunteers' registries identified

Patient advocacy group needs for volunteers registries identified

Updated report on unanswered COVID-19 vaccines and vaccination priority questions for future trials

Updated report on unanswered COVID19 vaccines and vaccination priority questions for future trials

Terms of Reference documents defining CB and TCB operations and NC responsibilities
D5.8 List of standardised data for vaccine trial protocol design

List of standardised data for vaccine trial protocol design

Midterm Recruitment Report
Quality policy
Report on annual consortium meeting year 1
WP13 Registration Number for study from WHO- or ICMJE-approved registry

Registration Number for study from WHO or ICMJEapproved registry

D5.4 Updated report on unanswered COVID-19 vaccines and vaccination priority questions for future trials

Updated report on unanswered COVID19 vaccines and vaccination priority questions for future trials

D5.2 First report on unanswered COVID-19 vaccines and vaccination priority questions for future trials

First report on unanswered COVID19 vaccines and vaccination priority questions for future trials

D5.3 Updated report on unanswered COVID-19 vaccines and vaccination priority questions for future trials

Updated report on unanswered COVID19 vaccines and vaccination priority questions for future trials

Report on annual consortium meeting year 2
ORDP

VACCELERATE data management and data sharing plan DMP

Phase 3 vaccine trial master protocol templates

Module 1 of the Study Nurse course online
Priority list and road map for innovative immune and genetic assays
D8.3 First set of promotion tools and harmonized educational material (flyers, 3D cards, booklets) for specific volunteer groups in clinical trials, interconnected with WP2

First set of promotion tools and harmonized educational material flyers 3D cards booklets for specific volunteer groups in clinical trials interconnected with WP2Additional Type R

D2.5 Inventory and gap analysis of existing public outreach material

Inventory and gap analysis of existing public outreach material

D3.4 GCP course online

GCP course online

D2.2 Communication tool kit

Communication tool kit

First version of centralised, freely accessible database of standardised immune monitoring and genetic assays, including protocols, SOPs and quality control data

First version of centralised freely accessible database of standardised immune monitoring and genetic assays including protocols SOPs and quality control data

D2.1 VACCELERATE website online

VACCELERATE website online

R-Requirement Nr.7

VACCELERATE data management and data sharing plan DMP

Publicaciones

Enhancing Public Health Communication Regarding Vaccine Trials: Design and Development of the Pan-European VACCELERATE Toolkit

Autores: Christos D Argyropoulos; Janina Leckler; Jon Salmanton-García; Marinos Constantinou; Alexandra Alexandrou; Sophia Themistocleous; Evgenia Noula; George Shiamakkides; Andria Nearchou; Fiona A Stewart; Kerstin Albus; Markela Koniordou; Ioannis Kopsidas; Orly Spivak ; Margot Hellemans; Greet Hendrickx; Ruth Joanna Davis; Anna Maria Azzini; Paula Valle Simon; Antonio Javier Carcas-
Publicado en: JMIR Public Health and Surveillance, 2023, ISSN 2369-2960
Editor: JMIR Publications. J. Med. Internet Res.
DOI: 10.2196/44491

A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern

Autores: Nina Urke Ertesvåg, Julie Xiao, Fan Zhou, Sonja Ljostveit, Helene Sandnes, Sarah Lartey, Marianne Sævik, Lena Hansen, Anders Madsen, Kristin G. I. Mohn, Elisabeth Fjelltveit, Jan Stefan Olofsson, Tiong Kit Tan, Pramila Rijal, Lisa Schimanski, Siri Øyen, Karl Albert Brokstad, Susanna Dunachie, Anni Jämsén, William S. James, Adam C. Harding, Heli Harvala, Dung Nguyen, David Roberts, PHE Virolog
Publicado en: Communications Medicine, 2022, ISSN 2730-664X
Editor: London Nature Portfolio
DOI: 10.1038/s43856-022-00091-x

A pilot surveillance report of SARS-CoV-2 rapid antigen test results among volunteers in Germany, 1st week of July 2022

Autores: Jannik Stemler, Jon Salmanton-García, Ben Weise, Christina Többen, Carolin Joisten, Julian Fleig, Oliver A. Cornely on behalf of the VACCELERATE Consortium
Publicado en: Infection, 2022, ISSN 0300-8126
Editor: Urban und Vogel Medien und Medizin Verlagsgesellschaft mbH
DOI: 10.1007/s15010-022-01931-7

Monkeypox diagnostic and treatment capacity at epidemic onset: A VACCELERATE online survey.

Autores: Jan Hendrik Grothe; Oliver A. Cornely; Jon Salmanton-García
Publicado en: Journal of Infection and Public Health, Edición 4, 2022, Página(s) 043–1046, ISSN 1876-0341
Editor: Elsevier BV
DOI: 10.1016/j.jiph.2022.08.008

VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment

Autores: Jon Salmanton-García; Fiona A. Stewart; Sarah Heringer; Markela Koniordou; Elena Álvarez-Barco; Christos D. Argyropoulos; Sophia C. Themistocleous; Paula Valle-Simón; Orly Spivak; Lenka Součková; Christina Merakou; Maria Amélia Mendonça; Ruth Joanna Davis; Anna Maria Azzini; Helena H. Askling; Sirkka Vene; Pierre Van Damme; Angela Steinbach; George Shiamakkides; Danila Seidel; Ole F. Olesen
Publicado en: Vaccine, Edición 1, 2022, Página(s) 4090-4097, ISSN 0264-410X
Editor: Elsevier BV
DOI: 10.1016/j.vaccine.2022.05.022

Monkeypox in children and adult women in Europe: Results from a flash VACCELERATE pilot survey

Autores: Jon Salmanton-García; Jan Grothe; Oliver Cornely
Publicado en: Enfermedades Infecciosas y Microbiología Clínica, Edición 2, 2022, ISSN 0213-005X
Editor: Ediciones Doyma S.A.
DOI: 10.1016/j.eimc.2022.08.002

Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days

Autores: Sergio Gil-Manso, Diego Carbonell, Luis López-Fernández, Iria Miguens, Roberto Alonso, Ismael Buño, Patricia Muñoz, Jordi Ochando, Marjorie Pion and Rafael Correa-Rocha
Publicado en: Frontiers in Immunology, 2021, ISSN 1664-3224
Editor: Lausanne Frontiers Media S.A. 2010
DOI: 10.3389/fimmu.2021.726960

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial AND Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

Autores: Alberto M Borobia, Antonio J Carcas, Mayte Pérez-Olmeda, Luis Castaño, María Jesús Bertran, Javier García-Pérez, Magdalena Campins, Antonio Portolés, María González-Pérez, María Teresa García Morales, Eunate Arana-Arri, Marta Aldea, Francisco Díez-Fuertes, Inmaculada Fuentes, Ana Ascaso, David Lora, Natale Imaz-Ayo, Lourdes E Barón-Mira, Antonia Agustí, Carla Pérez-Ingidua, Agustí
Publicado en: The Lancet, 2021, ISSN 0140-6736
Editor: The Lancet Publishing Group
DOI: 10.1016/s0140-6736(21)01420-3

Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination

Autores: Maria Gonzalez-Perez, Maria Montes-Casado, Patricia Conde, Isabel Cervera, Jana Baranda, Marcos J. Berges-Buxeda, Mayte Perez-Olmeda, Rodrigo Sanchez-Tarjuelo, Alberto Utrero-Rico, Daniel Lozano-Ojalvo, Denis Torre, Megan Schwarz, Ernesto Guccione, Carmen Camara, M Rosario Llópez-Carratalá, Emilio Gonzalez-Parra, Pilar Portoles, Alberto Ortiz, Jose Portoles and Jordi Ochando
Publicado en: Frontiers in Immunology, 2022, ISSN 1664-3224
Editor: Lausanne Frontiers Media S.A. 2010
DOI: 10.3389/fimmu.2022.845882

Efficacy and safety of COVID‐19 vaccines

Autores: Graña C, Ghosn L, Evrenoglou T, Jarde A, Minozzi S, Bergman H, Buckley BS, Probyn K, Villanueva G, Henschke N, Bonnet H, Assi R, Menon S, Marti M, Devane D, Mallon P, Lelievre JD, Askie LM, Kredo T, Ferrand G, Davidson M, Riveros C, Tovey D, Meerpohl JJ, Grasselli G, Rada G, Hróbjartsson A, Ravaud P, Chaimani A, Boutron I
Publicado en: Cochrane database of systematic reviews, 2022, ISSN 1469-493X
Editor: John Wiley & Sons Inc.
DOI: 10.1002/14651858.cd015477

Factors that impact on recruitment to vaccine trials in the context of a pandemic or epidemic: a qualitative evidence synthesis (Review)

Autores: Pauline Meskell, Linda M Biesty, Maura Dowling, Kevin Roche, Elaine Meehan, Claire Glenton, Declan Devane, Sasha Shepperd, Andrew Booth, Rebecca Cox, Xin Hui S Chan, Catherine Houghton
Publicado en: Cochrane Database of Systematic Reviews, 2023, ISSN 1469-493X
Editor: John Wiley & Sons Inc.
DOI: 10.1002/14651858.mr000065.pub2

Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR

Autores: Megan Schwarz, Denis Torre, Daniel Lozano-Ojalvo, Anthony T. Tan, Tommaso Tabaglio, Slim Mzoughi, Rodrigo Sanchez-Tarjuelo, Nina Le Bert, Joey Ming Er Lim, Sandra Hatem, Kevin Tuballes, Carmen Camara, Eduardo Lopez-Granados, Estela Paz-Artal, Rafael Correa-Rocha, Alberto Ortiz, Marcos Lopez-Hoyos, Jose Portoles, Isabel Cervera, Maria Gonzalez-Perez, Irene Bodega-Mayor, Patricia Conde, Jesús Oteo-
Publicado en: Nature Biotechnology, 2022, ISSN 1087-0156
Editor: Nature Publishing Group
DOI: 10.1038/s41587-022-01347-6

A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network.

Autores: Julia M. Neuhann; Jannik Stemler; Antonio Carcas; Jesús Frías-Iniesta; Ullrich Bethe; Sarah Heringer; Lea Tischmann; Marouan Zarrouk; Arnd Cüppers; Franz König; Martin Posch; Oliver A. Cornely
Publicado en: Trials, Edición 2, 2022, ISSN 1745-6215
Editor: BioMed Central
DOI: 10.1186/s13063-022-06791-y

Dynamics of humoral and cellular immune responses after homologous and heterologous SARS-CoV-2 vaccination with ChAdOx1 nCoV-19 and BNT162b2

Autores: Emanuel Vogel, Katharina Kocher, Alina Priller, Cho-Chin Cheng, Philipp Steininger, Bo-Hung Liao, Nina Körber, Annika Willmann, Pascal Irrgang, Jürgen Held, Carolin Moosmann, Viviane Schmidt, Stephanie Beileke, Monika Wytopil, Sarah Heringer, Tanja Bauer, Ronja Brockhoff, Samuel Jeske, Hrvoje Mijocevic, Catharina Christa, Jon Salmanton-García, Kathrin Tinnefeld, Christian Bogdan, Sarah Yazici,
Publicado en: eBioMedicine, 2022, ISSN 2352-3964
Editor: Elsevier BV
DOI: 10.1016/j.ebiom.2022.104294

VACCELERATE Site Network: Real-time definition of clinical study capacity in Europe

Autores: Jon Salmanton-García, Pauline Wipfler, Paula Valle-Simón, Christina Merakou, Ioannis Kopsidas, Ullrich Bethe, Angela Steinbach, Orly Spivak, Lenka Součková, Maria Amélia Mendonça, Markela Koniordou, Margot Hellemans, Jesus Frías-Iniesta, Ruth Joanna Davis, Imre Barta, Anna Maria Azzini, Helena H. Askling, Christos D. Argyropoulos, Elena Álvarez-Barco, Murat Akova, Marc M.J. Bonten, Miriam
Publicado en: Vaccine, 2023, ISSN 0264-410X
Editor: Elsevier BV
DOI: 10.1016/j.vaccine.2023.05.006

Factors that impact on recruitment to vaccine trials during a pandemic or epidemic: a qualitative evidence synthesis [protocol]

Autores: Pauline Meskell, Linda M Biesty, Maura Dowling, Elaine Meehan, Claire Glenton, Declan Devane, Sasha Shepperd, Andrew Booth, Rebecca Cox, Xin Hui S Chan, Catherine Houghton
Publicado en: Cochrane database of systematic reviews, 2022, ISSN 1469-493X
Editor: John Wiley & Sons Inc.
DOI: 10.1002/14651858.mr000065

Vaccination rates in Europe are not associated with online media intensity

Autores: Catarina Luís, Veronica Romina Di Marzo, Mandeep Kaur, Christos D. Argyropoulos, Declan Devane, Fiona Anne Stewart, George Antoniou, Greet Hendrickx, Helena Hervius Askling, Margot Hellemans, Miriam Cohen, Orly Spivak, Pierre Van Damme, Rebecca Jane Cox, Sirkka Vene, Sofie Sibia, Zoi Dorothea Pana and Ole F. Olesen, on behalf of VACCELERATE Consortium
Publicado en: Journal of Science Communication (JCOM), Edición approx. 7 issues per year, 2022, ISSN 1824-2049
Editor: Scuola Internazionale Superiore di Studi Avanzati (SISSA)
DOI: 10.22323/2.21050205

Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals

Autores: Daniel Lozano-Ojalvo, Carmen Camara, Eduardo Lopez-Granados, Pilar Nozal, Lucía del Pino-Molina, Luz Yadira Bravo-Gallego, Estela Paz-Artal, Marjorie Pion, Rafael Correa-Rocha, Alberto Ortiz, Marcos Lopez-Hoyos, Marta Erro Iribarren, Jose Portoles, Maria Pilar Rojo-Portoles, Gloria Ojeda, Isabel Cervera, Maria Gonzalez-Perez, Irene Bodega-Mayor, Maria Montes-Casado, Pilar Portoles, Mayte Perez-Ol
Publicado en: Cell Reports, 2021, ISSN 2211-1247
Editor: Cell Press
DOI: 10.1016/j.celrep.2021.109570

Heterologous prime–boost vaccination with ChAdOx1 nCoV-19 and BNT162b2

Autores: Matthias Tenbusch, Sofie Schumacher, Emanuel Vogel, Alina Priller, Jürgen Held, Philipp Steininger, Stephanie Beileke, Pascal Irrgang, Ronja Brockhoff, Jon Salmanton-García, Kathrin Tinnefeld, Hrvoje Mijocevic, Kilian Schober, Christian Bogdan, Sarah Yazici, Percy Knolle, Oliver A. Cornely, Klaus Überla, Ulrike Protzer on behalf of the DZIF-Vaccelerate-CoVaKo study team
Publicado en: The Lancet Infectious diseases, 2021, ISSN 1473-3099
Editor: The Lancet Publishing Group
DOI: 10.1016/s1473-3099(21)00420-5

Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccination

Autores: Grace Kenny, Riya Negi, Sophie O'Reilly, Alejandro Garcia-Leon, Dana Alalwan, Colette Marie Gaillard, Gurvin Saini, Rosana Inzitari, Eoin R. Feeney, Obada Yousif, Aoife G Cotter, Eoghan de Barra, Corinna Sadlier, Fiona Crispie, Peter Doran, Virginie Gautier, Patrick W.G. Mallon, on behalf of the All Ireland Infectious Diseases cohort study
Publicado en: Journal of Immunological Methods, 2022, ISSN 0022-1759
Editor: Elsevier BV
DOI: 10.1016/j.jim.2022.113345

Cellular immunity Assay (CI)

Autores: Ochando, Jordi; VACCELERATE (Projekt)
Publicado en: Fachrepositorium Lebenswissenschaften, Edición 1, 2022
Editor: Deutsche Zentralbibliothek für Medizin (ZB MED) - Infor-mations-zentrum Lebens-wissen-schaften
DOI: 10.4126/frl01-006434987

Preparation of PBMCs

Autores: VACCELERATE (Projekt); Kelly, Christine; Garcia Leon, Alejandro Abner
Publicado en: Fachrepositorium Lebenswissenschaften, Edición 1, 2021
Editor: Deutsche Zentralbibliothek für Medizin (ZB MED) - Infor-mations-zentrum Lebens-wissen-schaften
DOI: 10.4126/frl01-006434993

Anti-Sars-Cov-2 (Spike, Nucleocapsid and RBD) IgG Protocol for MSD Platform

Autores: VACCELERATE (Projekt); Garcia Leon, Alejandro Abner
Publicado en: Fachrepositorium Lebenswissenschaften, Edición 1, 2021
Editor: Deutsche Zentralbibliothek für Medizin (ZB MED) - Infor-mations-zentrum Lebens-wissen-schaften

Whole blood processing

Autores: VACCELERATE (Projekt); Kelly, Christine; Garcia Leon, Alejandro Abner
Publicado en: Fachrepositorium Lebenswissenschaften, Edición 1, 2021
Editor: Deutsche Zentralbibliothek für Medizin (ZB MED) - Infor-mations-zentrum Lebens-wissen-schaften
DOI: 10.4126/frl01-006434995

Development of a Novel Medium Throughput Flow-Cytometry Based Micro-Neutralisation Test for SARS-CoV-2 with Applications in Clinical Vaccine Trials and Antibody Screening

Autores: Sophie O’Reilly, Grace Kenny, Tamara Alrawahneh, Nathan Francois, Matthew Angeliadis, Valentin de Masson d’Autume, Alejandro Garcia Leon, Eoin R. Feeney, Obada Yousif, Aoife Cotter, Eoghan de Barra, Mary Horgan, Patrick WG Mallon, Virginie Gautier
Publicado en: medRxiv, 2023
Editor: Cold Spring Harbor Laboratory
DOI: 10.1101/2023.01.18.23284713

Additional file 2 of A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network

Autores: Neuhann, Julia M.; Stemler, Jannik; Carcas, Antonio; Frías-Iniesta, Jesús; Bethe, Ullrich; Heringer, Sarah; Tischmann, Lea; Zarrouk, Marouan; Cüppers, Arnd; König, Franz; Posch, Martin; Cornely, Oliver A.
Publicado en: Trials, Edición 1, 2022
Editor: BioMed Central
DOI: 10.6084/m9.figshare.21303517

Sample Handling

Autores: VACCELERATE (Projekt); Kelly, Christine; Garcia Leon, Alejandro Abner
Publicado en: Fachrepositorium Lebenswissenschaften, Edición 1, 2021
Editor: Deutsche Zentralbibliothek für Medizin (ZB MED) - Infor-mations-zentrum Lebens-wissen-schaften
DOI: 10.4126/frl01-006434994

Additional file 1 of A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network

Autores: Neuhann, Julia M.; Stemler, Jannik; Carcas, Antonio; Frías-Iniesta, Jesús; Bethe, Ullrich; Heringer, Sarah; Tischmann, Lea; Zarrouk, Marouan; Cüppers, Arnd; König, Franz; Posch, Martin; Cornely, Oliver A.
Publicado en: Trials, Edición 2, 2022
Editor: BioMed Central
DOI: 10.6084/m9.figshare.21303514

Immunogenicity and Reactogenicity of a First Booster with NT162b2or Full-Dose mRNA-1273: A Randomised VACCELERATE Trial in Adults ≥75 Years (EU-COVAT-1)

Autores: Julia Neuhann, Jannik Stemler, Antonio Carcas, Jesús Frías, Murat Akova, Ullrich Bethe, Sarah Heringer, Jon Salmanton-Garcia, Lea Tischmann, Marouan Zarrouk, Arnd Cüpers, Jan H. Grothe, Alejandro Abner Garcia Leon, Patrick Mallon, Riya Negi, Colette Gaillard, Gurvin Saini, Christine Lammens, An Hotterbeekx, Katherine Loens, Surbhi Malhotra-Kumar, Herman Goosens, Samir Kumar-Singh, Franz König,
Publicado en: Preprints with THE LANCET, 2023
Editor: SSRN - Elsevier

Haemagglutination assay (HAT)

Autores: Cox, Rebecca; VACCELERATE (Projekt)
Publicado en: Fachrepositorium Lebenswissenschaften, Edición 1, 2021
Editor: Deutsche Zentralbibliothek für Medizin (ZB MED) - Infor-mations-zentrum Lebens-wissen-schaften
DOI: 10.4126/frl01-006434989

Collection and Handling of Biological Materials

Autores: VACCELERATE (Projekt); Kelly, Christine; Garcia Leon, Alejandro Abner
Publicado en: Fachrepositorium Lebenswissenschaften, Edición 1, 2021
Editor: Deutsche Zentralbibliothek für Medizin (ZB MED) - Informationszentrum Lebenswissenschaften
DOI: 10.4126/frl01-006434990

Current evidence regarding treatment of hospitalized Covid-19 patients. Summary of main results: April 2022

Autores: The COVID-NMA team
Publicado en: Edición 4, 2022
Editor: Zenodo
DOI: 10.5281/zenodo.6452030

Flow Cytometry based-Live SARS-CoV-2 Micro-Neutralisation assay

Autores: Gautier, Virginie; VACCELERATE (Projekt)
Publicado en: Fachrepositorium Lebenswissenschaften, Edición 1, 2021
Editor: Deutsche Zentralbibliothek für Medizin (ZB MED) - Infor-mations-zentrum Lebens-wissen-schaften
DOI: 10.4126/frl01-006434991

Derechos de propiedad intelectual

EUVAP

Número de solicitud/publicación: DE 302021211078
Fecha: 2021-03-03

Vaccelerate

Número de solicitud/publicación: DE 302021226584
Fecha: 2022-03-11

VACCELERATE - European Corona Vaccine Trial Accelerator Platform

Resultado final

Publicaciones

Derechos de propiedad intelectual

Compartir esta página

Descargar